1. Adenovirus Viremia in Adult CD34+ Selected Hematopoietic Cell Transplant Recipients: Low Incidence and High Clinical Impact 
Yeon Joo Lee, Yao-Ting Huang, Seong Jin Kim, Molly Maloy, Roni Tamari, Sergio A. Giralt, Esperanza B. Papadopoulos, Ann A. Jakubowski, Genovefa A. Papanicolaou 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 1, Pages (January 2016)
DOI: /j.bbmt
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
(A) Duration and outcomes of patients with ADV viremia. Each horizontal line represents a patient. X axis indicates days after stem cell infusion; horizontal line, duration of ADV viremia; , ADV disease diagnosis; Δ, start of treatment; X, death. All patients had ADV in stool. In addition, 2 patients had ADV in urine, 1 patient had ADV in a respiratory specimen, and 2 had ADV in urine and respiratory specimens. (B) Patients A through F had ADV disease. VL indicates viral load; Max, maximum; Tx, treatment; D, day from transplant; CDV, intravenous cidofovir; RESP, respiratory specimens (bronchoalveolar lavage, nasopharyngeal swab).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions